Arcus Biosciences, Inc. (RCUS) Ownership

$13.35

south_east
-$0.03 (-0.19%)
Day's range
$13.21
Day's range
$13.58

Arcus Biosciences, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
GILEAD SCIENCES, INC. 11/13/2025 31.42 M $427.38 M   0.00% 29.62%
BLACKROCK, INC. 11/12/2025 11.81 M $160.63 M   3.08% 11.13%
VANGUARD GROUP INC 11/07/2025 6.63 M $90.16 M   1.12% 6.25%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2025 4.33 M $58.92 M   -27.39% 4.08%
WOODLINE PARTNERS LP 11/14/2025 3.77 M $51.27 M   -5.76% 3.55%
SUVRETTA CAPITAL MANAGEMENT, LLC 11/14/2025 3.69 M $50.17 M   0.00% 3.48%
STATE STREET CORP 11/14/2025 3.39 M $46.17 M   -6.50% 3.20%
SIREN, L.L.C. 11/13/2025 2.91 M $39.60 M   80.64% 2.74%
FMR LLC 11/13/2025 2.30 M $31.23 M   -10.78% 2.16%
BALYASNY ASSET MANAGEMENT L.P. 11/14/2025 1.77 M $24.11 M   3.81% 1.67%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 1.60 M $21.74 M   0.13% 1.51%
MORGAN STANLEY 11/14/2025 1.54 M $20.89 M   4.51% 1.45%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 1.50 M $20.43 M   -9.48% 1.42%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 11/07/2025 1.42 M $19.31 M   1.74% 1.34%
BANK OF AMERICA CORP /DE/ 11/14/2025 1.36 M $18.51 M   173.46% 1.28%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 1.27 M $17.22 M   35.28% 1.19%
BARCLAYS PLC 11/12/2025 1.27 M $17.22 M   0.00% 1.19%
SOFINNOVA INVESTMENTS, INC. 11/14/2025 1.22 M $16.62 M   0.51% 1.15%
RA CAPITAL MANAGEMENT, L.P. 11/14/2025 1.14 M $15.45 M   0.00% 1.07%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/17/2025 1.12 M $15.23 M   39.09% 1.06%
GOLDMAN SACHS GROUP INC 11/14/2025 950.59 K $12.93 M   46.68% 0.90%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 871.15 K $11.85 M   12.15% 0.82%
FISHER ASSET MANAGEMENT, LLC 11/12/2025 729.15 K $9.92 M   727.05% 0.69%
NORTHERN TRUST CORP 11/14/2025 707.80 K $9.63 M   2.39% 0.67%
PARKMAN HEALTHCARE PARTNERS LLC 11/14/2025 652.68 K $8.88 M   8.85% 0.62%
MILLENNIUM MANAGEMENT LLC 11/14/2025 634.94 K $8.64 M   -18.61% 0.60%
DAFNA CAPITAL MANAGEMENT LLC 11/14/2025 627.63 K $8.54 M   0.00% 0.59%
DECHENG CAPITAL LLC 11/14/2025 547.61 K $7.45 M   242.26% 0.52%
TWO SIGMA INVESTMENTS, LP 11/14/2025 471.52 K $6.41 M   15.51% 0.44%
BANK OF NEW YORK MELLON CORP 11/03/2025 470.21 K $6.39 M   -2.86% 0.44%
GRANAHAN INVESTMENT MANAGEMENT, LLC 11/14/2025 455.60 K $6.20 M   -7.14% 0.43%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 389.14 K $5.29 M   11.67% 0.37%
PDT PARTNERS, LLC 11/17/2025 388.34 K $5.28 M   -0.24% 0.37%
MACQUARIE GROUP LTD 11/13/2025 379.10 K $5.16 M   0.00% 0.36%
CANDRIAM S.C.A. 11/06/2025 378.44 K $5.15 M   100.00% 0.36%
SECTORAL ASSET MANAGEMENT INC 11/14/2025 368.07 K $5.01 M   43.07% 0.35%
HUDSON BAY CAPITAL MANAGEMENT LP 11/13/2025 340.00 K $4.62 M   -20.93% 0.32%
PRINCIPAL FINANCIAL GROUP INC 11/04/2025 334.52 K $4.55 M   -0.51% 0.32%
ABRDN PLC 11/07/2025 331.67 K $4.42 M   100.00% 0.31%
NORDEA INVESTMENT MANAGEMENT AB 10/27/2025 328.46 K $4.33 M   2.68% 0.31%
CITADEL ADVISORS LLC 11/14/2025 295.05 K $4.01 M   -51.73% 0.28%
INVESCO LTD. 11/13/2025 292.40 K $3.98 M   16.10% 0.28%
TWO SIGMA ADVISERS, LP 11/14/2025 285.40 K $3.88 M   -3.52% 0.27%
PUBLIC SECTOR PENSION INVESTMENT BOARD 11/06/2025 269.86 K $3.67 M   16.81% 0.25%
VESTAL POINT CAPITAL, LP 11/14/2025 250.00 K $3.40 M   100.00% 0.24%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 11/14/2025 239.97 K $3.26 M   -3.23% 0.23%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 11/13/2025 239.42 K $3.26 M   100.00% 0.23%
AXA INVESTMENT MANAGERS S.A. 11/14/2025 232.67 K $3.16 M   100.00% 0.22%
JANE STREET GROUP, LLC 11/14/2025 225.63 K $3.07 M   -53.20% 0.21%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 219.30 K $2.98 M   -40.42% 0.21%

Arcus Biosciences, Inc. institutional Ownership - FAQ's

During the previous two years, 245 institutional investors and hedge funds held shares of Arcus Biosciences, Inc.. The most heavily invested institutionals were:

GILEAD SCIENCES, INC.: 31.42 M

BlackRock, Inc.: 11.81 M

VANGUARD GROUP INC: 6.63 M

Point72 Asset Management, L.P.: 4.33 M

Woodline Partners LP: 3.77 M

SUVRETTA CAPITAL MANAGEMENT, LLC: 3.69 M

94.83% of Arcus Biosciences, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 116.82 M shares in the last 24 months. This purchase volume represents approximately $1.56 B in transactions.